{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T17:37:46Z","timestamp":1775151466288,"version":"3.50.1"},"reference-count":112,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2006,1,25]],"date-time":"2006-01-25T00:00:00Z","timestamp":1138147200000},"content-version":"vor","delay-in-days":1546,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of the New York Academy of Sciences"],"published-print":{"date-parts":[[2001,11]]},"abstract":"<jats:p><jats:bold>A<jats:sc>bstract<\/jats:sc>: <\/jats:bold> HIV infection is accompanied by disturbances in lipid and glucose metabolism, which are further compounded by changes induced by antiretroviral drugs. There is increasing concern that these changes will lead to an epidemic of cardiovascular disease. Cardiovascular disease will no doubt increase, but current data indicate that the average absolute levels are likely to remain low, although patients with additional risks (smoking, hypertension, diabetes, age, family history, etc.) are certainly more susceptible. The complications of therapy need to be taken into account when deciding on the time of treatment, and reducing risk factors should become a routine aspect of the care of an HIV population that now lives longer as a result of highly active antiretroviral therapy.<\/jats:p>","DOI":"10.1111\/j.1749-6632.2001.tb03913.x","type":"journal-article","created":{"date-parts":[[2010,7,20]],"date-time":"2010-07-20T19:03:40Z","timestamp":1279652620000},"page":"200-213","source":"Crossref","is-referenced-by-count":13,"title":["Cardiovascular Disease Risk Factors in HIV\u2010Infected Patients in the HAART Era"],"prefix":"10.1111","volume":"946","author":[{"given":"M.","family":"GALLI","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. L.","family":"RIDOLFO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"GERVASONI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,1,25]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199803263381301"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199912240-00002"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199807000-00003"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)03391-1"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)06102-4"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a009572"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)79053-X"},{"key":"e_1_2_5_9_2","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1016\/S0140-6736(05)78643-8","article-title":"Vascular complications associated with the use of HIV protease inhibitors","volume":"351","author":"Gallet B.","year":"1998","journal-title":"Lancet"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)78644-X"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)26026-0"},{"key":"e_1_2_5_12_2","first-page":"2499","article-title":"Severe coronary artery disease in a young HIV infected man with no cardiovascular risk factors who was treated with indinavir","volume":"12","author":"Karmochkine M.","year":"1998","journal-title":"AIDS"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199815000-00024"},{"key":"e_1_2_5_14_2","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1097\/00002030-199910010-00033","article-title":"Sudden cardiac death in a patient on 2 years of highly active antiretroviral treatment: a case report","volume":"13","author":"Koppel K.","year":"1999","journal-title":"AIDS"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-131-7-199910050-00032"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1086\/313995"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(89)90225-8"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.74.5.1045"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.76.3.559"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)91058-G"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.79.1.8"},{"key":"e_1_2_5_22_2","first-page":"M8","article-title":"The emergence of triglycerides as a significant independent risk in coronary artery disease","volume":"19","author":"Assmann G.","year":"1998","journal-title":"Eur. Heart J."},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.3109\/15513818709177129"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0923-2516(06)80033-6"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1998.0636j.x"},{"key":"e_1_2_5_26_2","first-page":"127","article-title":"Endothelial cell dysfunction in HIV infection","volume":"5","author":"Lafeuillade A.","year":"1992","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"e_1_2_5_27_2","first-page":"1887","article-title":"Aortic endothelium in HIV\u20101 infection","volume":"149","author":"Zietz C.","year":"1996","journal-title":"Am. J. Pathol."},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1615171"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1656027"},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.3109\/10623320009072210"},{"key":"e_1_2_5_31_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V96.4.1438"},{"key":"e_1_2_5_32_2","doi-asserted-by":"publisher","DOI":"10.1089\/088922299310160"},{"key":"e_1_2_5_33_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.1890470411"},{"key":"e_1_2_5_34_2","doi-asserted-by":"publisher","DOI":"10.1038\/icb.1995.22"},{"key":"e_1_2_5_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)09424-X"},{"key":"e_1_2_5_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)61703-5"},{"key":"e_1_2_5_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)63513-1"},{"key":"e_1_2_5_38_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-127-10-199711150-00016"},{"key":"e_1_2_5_39_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-127-10-199711150-00017"},{"key":"e_1_2_5_40_2","doi-asserted-by":"publisher","DOI":"10.1345\/aph.19231"},{"key":"e_1_2_5_41_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199815000-00001"},{"key":"e_1_2_5_42_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199907090-00001"},{"key":"e_1_2_5_43_2","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-199907010-00005"},{"key":"e_1_2_5_44_2","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/00126334-200001010-00005","article-title":"Hyperlipidemia and insulin resistance are induced by protease inhibitors independent of changes in body composition in patients with HIV infection","volume":"23","author":"Mulligan K.","year":"2000","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"2","key":"e_1_2_5_45_2","first-page":"34","volume":"4","author":"Dub\u00e9 M.P.","year":"1999","journal-title":"Effect of initiating indinavir therapy on glucose metabolism in HIV-infected patients: results of minimal model analysis. Antiviral Ther."},{"key":"e_1_2_5_46_2","unstructured":"Glesby M.et al.1998. Collected abstracts of 6thConference on Retroviruses and Opportunistic Infections (Chicago IL) no. 650. Foundation for Retroviruses and Human Health."},{"key":"e_1_2_5_47_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.84.6.1932"},{"key":"e_1_2_5_48_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.C000228200"},{"issue":"5","key":"e_1_2_5_49_2","first-page":"68","volume":"5","author":"Ridolfo A.L.","year":"2000","journal-title":"Incidence of lipodystrophy and metabolic alterations among patients receiving ART since primary HIV infection. Antiviral Ther."},{"key":"e_1_2_5_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/0895-4356(92)90173-K"},{"issue":"2","key":"e_1_2_5_51_2","first-page":"S15","article-title":"The cardiovascular risk associated with impaired glucose tolerance","volume":"13","author":"Jarret R.J.","year":"1996","journal-title":"Diabet. Med."},{"key":"e_1_2_5_52_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.2000.00938.x"},{"key":"e_1_2_5_53_2","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1097\/00002030-199905070-00009","article-title":"Reversion of metabolic abnormalities after switching from HIV\u20101 protease inhibitors to nevirapine","volume":"13","author":"Martinez E.","year":"1999","journal-title":"AIDS"},{"key":"e_1_2_5_54_2","unstructured":"Goebel F.D. & R.K. Walli. 2000. Collected abstracts of 7thConference on Retroviruses and Opportunistic Infections (San Francisco CA) no. 51. Foundation for Retroviruses and Human Health."},{"key":"e_1_2_5_55_2","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1097\/00002030-199905280-00023","article-title":"Effects of metformin on insulin resistance and central adiposity in patients receiving effective protease inhibitor therapy","volume":"13","author":"Saint\u2010Marc T.","year":"1999","journal-title":"AIDS"},{"key":"e_1_2_5_56_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.284.4.472"},{"key":"e_1_2_5_57_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(97)89422-3"},{"key":"e_1_2_5_58_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200002180-00001"},{"key":"e_1_2_5_59_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2000.01707.x"},{"key":"e_1_2_5_60_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199957060-00007"},{"key":"e_1_2_5_61_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199512073332303"},{"key":"e_1_2_5_62_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199811000-00024"},{"key":"e_1_2_5_63_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.100.7.700"},{"key":"e_1_2_5_64_2","doi-asserted-by":"publisher","DOI":"10.1086\/520231"},{"key":"e_1_2_5_65_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042560-200010010-00017"},{"key":"e_1_2_5_66_2","doi-asserted-by":"publisher","DOI":"10.1086\/317541"},{"key":"e_1_2_5_67_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-978655"},{"key":"e_1_2_5_68_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200001070-00006"},{"key":"e_1_2_5_69_2","unstructured":"Du Pont Pharmaceuticals. 1998. Sustiva (efavirenz capsules) [package insert]. Wilmington DE."},{"issue":"2","key":"e_1_2_5_70_2","first-page":"58","volume":"4","author":"Moyle G.J.","year":"1999","journal-title":"Lipid elevations during non-nucleoside RTI (NNRTI) therapy: a cross-sectional analysis [abstract]. Antiviral Ther."},{"key":"e_1_2_5_71_2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00002030-200001070-00005","article-title":"Fat distribution evaluated by computed tomography and metabolic abnormalities in patients undergoing antiretroviral therapy: preliminary results of the LIPOCO study","volume":"14","author":"Saint\u2010Marc T.","year":"2000","journal-title":"AIDS"},{"key":"e_1_2_5_72_2","unstructured":"Galli M.et al.2000. Collected abstracts of 40thInterscience Conference on Antimicrobial Agents and Chemotherapy (Toronto Ontario Canada) no. 1292. American Society of Microbiology."},{"key":"e_1_2_5_73_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042560-200011010-00014"},{"key":"e_1_2_5_74_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.eurheartj.a060388"},{"key":"e_1_2_5_75_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.100.5.475"},{"key":"e_1_2_5_76_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(96)00159-2"},{"key":"e_1_2_5_77_2","unstructured":"Ruiz L.et al.2000. Collected abstracts of 7thConference on Retroviruses and Opportunistic Infections (San Francisco CA) no. 1292. Foundation for Retroviruses and Human Health."},{"key":"e_1_2_5_78_2","unstructured":"Tebas P.et al.2000. Collected abstracts of 7thConference on Retroviruses and Opportunistic Infections (San Francisco CA) no. 45. Foundation for Retroviruses and Human Health."},{"key":"e_1_2_5_79_2","unstructured":"Bonnet E.et al.2000. Collected abstracts of 7thConference on Retroviruses and Opportunistic Infections (San Francisco CA) no. 49. Foundation for Retroviruses and Human Health."},{"key":"e_1_2_5_80_2","unstructured":"Gharakhanian S.et al.2000. Collected abstracts of 7thConference on Retroviruses and Opportunistic Infections (San Francisco CA) no. 46. Foundation for Retroviruses and Human Health."},{"key":"e_1_2_5_81_2","unstructured":"Martinez E.et al.2000. Collected abstracts of 7thConference on Retroviruses and Opportunistic Infections (San Francisco CA) no. 50. Foundation for Retroviruses and Human Health."},{"issue":"2","key":"e_1_2_5_82_2","first-page":"48","volume":"4","author":"Moyle G.J.","year":"1999","journal-title":"Changes in visceral adipose tissue and blood lipids in persons reporting fat redistribution syndrome switched from PI therapy to efavirenz. Antiviral Ther."},{"issue":"2","key":"e_1_2_5_83_2","first-page":"55","volume":"4","author":"Rozenbaum W.","year":"1999","journal-title":"Prospective follow-up of a PI substitution for efavirenz in patients with HIV-related lipodystrophy syndrome. Antiviral Ther."},{"key":"e_1_2_5_84_2","unstructured":"Goebel F. & R.K. Walli. 2000. Collected abstracts of 7thConference on Retroviruses and Opportunistic Infections (San Francisco CA) no. 51. Foundation for Retroviruses and Human Health."},{"key":"e_1_2_5_85_2","unstructured":"Opravil M.et al.2000. Collected abstracts of 7thConference on Retroviruses and Opportunistic Infections (San Francisco CA) no. 457. Foundation for Retroviruses and Human Health."},{"key":"e_1_2_5_86_2","unstructured":"Rozenbaum W.et al.2000. Collected abstracts of 7thConference on Retroviruses and Opportunistic Infections (San Francisco CA) no. 47. Foundation for Retroviruses and Human Health."},{"key":"e_1_2_5_87_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199806000-00001"},{"key":"e_1_2_5_88_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)77776-X"},{"key":"e_1_2_5_89_2","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1097\/00002030-199909100-00009","article-title":"A syndrome of peripheral fat wasting (lipodystrophy) in patients receiving long term nucleoside analogue therapy","volume":"13","author":"Saint\u2010Marc T.","year":"1999","journal-title":"AIDS"},{"key":"e_1_2_5_90_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)64011-1"},{"key":"e_1_2_5_91_2","doi-asserted-by":"publisher","DOI":"10.1086\/597649"},{"key":"e_1_2_5_92_2","doi-asserted-by":"publisher","DOI":"10.1086\/517654"},{"key":"e_1_2_5_93_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)11443-X"},{"key":"e_1_2_5_94_2","doi-asserted-by":"publisher","DOI":"10.1086\/514639"},{"key":"e_1_2_5_95_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)11518-5"},{"key":"e_1_2_5_96_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199903110-00004"},{"key":"e_1_2_5_97_2","first-page":"107","article-title":"Changes in body habitus and serum lipid abnormalities in HIV\u2010positive women on highly active antiretroviral therapy (HAART)","volume":"21","author":"Dong K.L.","year":"1999","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"e_1_2_5_98_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199905070-00021"},{"key":"e_1_2_5_99_2","doi-asserted-by":"publisher","DOI":"10.1086\/317483"},{"key":"e_1_2_5_100_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V95.10.3191"},{"key":"e_1_2_5_101_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2000.tb05462.x"},{"key":"e_1_2_5_102_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.84.6.5740"},{"key":"e_1_2_5_103_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199911120-00007"},{"key":"e_1_2_5_104_2","unstructured":"David M.H.et al.2000. Collected abstracts of 38thAnnual Meeting of the Infectious Diseases Society of America (New Orleans LA) no. 355."},{"key":"e_1_2_5_105_2","unstructured":"Coplan P.et al.2000. Collected abstracts of 7thConference on Retroviruses and Opportunistic Infections: (San Francisco CA) no. 34. Foundation for Retroviruses and Human Health."},{"key":"e_1_2_5_106_2","first-page":"329","article-title":"Incidence of myocardial infarctions in HIV\u2010infected patients between 1983 and 1998: the Frankfurt HIV\u2010cohort study","volume":"5","author":"Rickerts V.","year":"2000","journal-title":"Eur. J. Med. Res."},{"key":"e_1_2_5_107_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199909100-00034"},{"key":"e_1_2_5_108_2","unstructured":"Egger M. 2000. Collected abstracts of 40thInterscience Conference on Antimicrobial Agents and Chemotherapy (Toronto Ontario Canada) no. 1374. American Society for Microbiology."},{"key":"e_1_2_5_109_2","unstructured":"Sosman J.M.et al.2000. Collected abstracts of 7thConference on Retroviruses and Opportunistic Infections (San Francisco CA) no. 29. Foundation for Retroviruses and Human Health."},{"key":"e_1_2_5_110_2","unstructured":"Depairon M.et al.2000. Collected abstracts of 7thConference on Retroviruses and Opportunistic Infections (San Francisco CA) no. 30. Foundation for Retroviruses and Human Health."},{"key":"e_1_2_5_111_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200011100-00001"},{"key":"e_1_2_5_112_2","unstructured":"Lenormand\u2010Walckenaer C.et al.2000. Collected abstracts of 40thInterscience Conference on Antimicrobial Agents and Chemotherapy (Toronto Ontario Canada) no. 1298. American Society for Microbiology."},{"key":"e_1_2_5_113_2","unstructured":"Talwani R.et al.2000. Collected abstracts of 40thInterscience Conference on Antimicrobial Agents and Chemotherapy (Toronto Ontario Canada): No. 1299. American Society for Microbiology."}],"container-title":["Annals of the New York Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1749-6632.2001.tb03913.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1749-6632.2001.tb03913.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/j.1749-6632.2001.tb03913.x","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1749-6632.2001.tb03913.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,10]],"date-time":"2023-09-10T09:30:20Z","timestamp":1694338220000},"score":1,"resource":{"primary":{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1749-6632.2001.tb03913.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,11]]},"references-count":112,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2001,11]]}},"alternative-id":["10.1111\/j.1749-6632.2001.tb03913.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1749-6632.2001.tb03913.x","archive":["Portico"],"relation":{},"ISSN":["0077-8923","1749-6632"],"issn-type":[{"value":"0077-8923","type":"print"},{"value":"1749-6632","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,11]]}}}